Tenax Therapeutics, Inc. (TENX)
 NASDAQ: TENX · Real-Time Price · USD
 7.47
 +0.24 (3.32%)
  At close: Oct 30, 2025, 4:00 PM EDT
7.43
 -0.04 (-0.54%)
  After-hours: Oct 30, 2025, 6:15 PM EDT
Tenax Therapeutics Market Cap
Tenax Therapeutics has a market cap or net worth of $298.73 million as of October 30, 2025. Its market cap has increased by 2,215.70% in one year.
Market Cap 
 298.73M
Enterprise Value 
 193.26M
1-Year Change 
 2,215.70%
Ranking 
 Category 
 Stock Price 
$7.47
Market Cap Chart
Since October 31, 2001, Tenax Therapeutics's market cap has increased from $13.80M to $298.73M, an increase of 2,064.68%. That is a compound annual growth rate of 13.66%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 33.00M | 56.40% | 
| Dec 31, 2024 | 21.10M | 219.70% | 
| Dec 29, 2023 | 6.60M | 32.00% | 
| Dec 30, 2022 | 5.00M | -80.92% | 
| Dec 31, 2021 | 26.20M | 11.49% | 
| Dec 31, 2020 | 23.50M | 147.37% | 
| Dec 31, 2019 | 9.50M | 427.78% | 
| Dec 31, 2018 | 1.80M | -86.96% | 
| Dec 29, 2017 | 13.80M | -74.82% | 
| Dec 30, 2016 | 54.80M | -40.63% | 
| Dec 31, 2015 | 92.30M | -14.54% | 
| Dec 31, 2014 | 108.00M | 125.94% | 
| Dec 31, 2013 | 47.80M | 123.36% | 
| Dec 31, 2012 | 21.40M | -45.69% | 
| Dec 30, 2011 | 39.40M | -13.41% | 
| Dec 31, 2010 | 45.50M | -62.86% | 
| Dec 31, 2009 | 122.50M | 213.30% | 
| Dec 31, 2008 | 39.10M | -10.93% | 
| Dec 31, 2007 | 43.90M | 92.54% | 
| Dec 29, 2006 | 22.80M | 25.97% | 
| Dec 30, 2005 | 18.10M | -40.66% | 
| Dec 31, 2004 | 30.50M | -57.04% | 
| Dec 31, 2003 | 71.00M | 332.93% | 
| Dec 31, 2002 | 16.40M | 18.84% | 
| Dec 31, 2001 | 13.80M | - | 
View and export this data all the way back to 2001. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 730.33B | 
| Johnson & Johnson | 449.57B | 
| AbbVie | 397.72B | 
| UnitedHealth Group | 321.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 239.27B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 216.57B |